Scleral Lens Market Size, Share, and Growth Forecast, 2026 - 2033

The global scleral lens market size is likely to be valued at US$0.5 billion in 2026 and is expected to reach US$1.0 billion by 2033, growing at a CAGR of 10.1% during the forecast period from 2026 to 2033, driven by the growing burden of corneal irregularities and ocular surface disorders that require advanced vision correction and therapeutic management.

According to the World Health Organization (WHO), at least 2.2 billion people were living with near- or distance-vision impairment globally in 2026, with nearly 1 billion cases remaining preventable or untreated. Refractive errors remain one of the leading causes of vision impairment worldwide, while conditions such as severe dry eye disease and keratoconus continue to increase demand for specialty contact lenses. Advancements in high-oxygen-permeable materials, digital corneal mapping, and customized scleral lens fitting technologies are improving patient outcomes and supporting broader adoption across ophthalmology and specialty eye-care practices.

Driver - Rising Prevalence of Keratoconus and Irregular Corneal Conditions

Keratoconus causes progressive thinning and distortion of the cornea, resulting in blurred vision that is often difficult to correct with conventional spectacles or soft contact lenses. Scleral lenses create a smooth optical surface by vaulting over the cornea and maintaining a fluid reservoir between the lens and the eye. This design significantly improves visual acuity and patient comfort.

Growing awareness among ophthalmologists and optometrists regarding the clinical benefits of scleral lenses is supporting wider adoption. Beyond keratoconus, scleral lenses are increasingly prescribed for patients with corneal ectasia, corneal scarring, pellucid marginal degeneration, and other irregular corneal disorders.

The growing availability of advanced diagnostic technologies such as corneal topography and tomography has improved early detection rates, enabling more patients to receive specialty lens treatment. As healthcare systems focus on preserving vision and reducing the need for invasive surgical interventions, scleral lenses are becoming an important therapeutic option.

Restraint - Practitioner Training and Fitting Complexity

Unlike conventional contact lenses, scleral lenses require detailed assessment of corneal shape, scleral anatomy, and ocular surface characteristics. Achieving an optimal fit often involves multiple evaluations and adjustments, increasing chair time for eye-care professionals. Many practitioners require specialized training and experience before offering scleral lens services confidently. Limited access to advanced fitting expertise, particularly in developing regions, can restrict patient adoption.

The fitting process frequently requires sophisticated diagnostic equipment, including corneal topographers and imaging systems, which may not be available in all eye-care settings. In addition, patient education regarding insertion, removal, cleaning, and maintenance can be more demanding than with traditional contact lenses. Variability in scleral anatomy complicates the fitting process, often necessitating customized lens designs. Treatment pathways can be longer and more resource-intensive.

Opportunity - Broader Indications and Pediatric/Refractive Applications

Expanding clinical indications represent a significant growth opportunity for the scleral lens market. While traditionally used for keratoconus and severe ocular surface disorders, scleral lenses are increasingly being considered for a broader range of conditions. Their ability to provide both vision correction and ocular surface protection makes them suitable for complex cases that cannot be managed effectively with conventional lenses.

Healthcare providers are exploring their use in post-surgical rehabilitation, corneal trauma recovery, and advanced dry eye management. As clinical evidence supporting these applications continues to grow, demand for customized scleral lens solutions is increasing across diverse patient groups.

Pediatric and refractive applications offer additional opportunities for market expansion. Advances in lens design, material technology, and digital fitting platforms are enabling practitioners to fit younger patients and individuals with unique visual requirements more effectively. Scleral lenses are gaining attention as a non-surgical option for patients seeking improved vision quality when traditional correction methods prove inadequate.

Lens Type Insights

Mini-scleral lenses are expected to lead, accounting for 48% of the revenue share in 2026, due to their ability to provide an effective balance between visual performance, patient comfort, and fitting convenience. These lenses vault over the cornea while resting on the sclera, creating a stable optical surface that improves vision for patients with keratoconus, corneal ectasia, and other irregular corneal conditions. A notable example includes the Onefit mini-scleral lens from Blanchard Lab (CooperVision Specialty EyeCare), which is widely used for managing irregular corneas and enhancing visual outcomes.

Full scleral lenses are likely to represent the fastest-growing segment, supported by their expanding use in advanced therapeutic eye-care applications. These lenses provide complete corneal vaulting and create a larger fluid reservoir, offering superior protection and hydration for compromised ocular surfaces. For example, the BostonSight SCLERAL lens developed by BostonSight is extensively utilized for the therapeutic management of complex corneal and ocular surface conditions.

Application Insights

Irregular cornea management is projected to lead the market, capturing around 62% of the revenue share in 2026, supported by the growing need for effective vision correction in patients with keratoconus, corneal ectasia, pellucid marginal degeneration, and corneal scarring. The increasing use of advanced corneal imaging technologies has also enhanced diagnosis and treatment planning, supporting broader adoption of scleral lenses. For instance, the Zenlens product from Bausch + Lomb is specifically designed to address complex irregular corneal conditions through customized fitting options.

Ocular surface disease therapy is likely to be the fastest-growing application due to the increasing prevalence of severe dry eye disease and related ocular surface disorders. Scleral lenses act as therapeutic devices by maintaining a continuous fluid reservoir between the lens and the eye, helping to protect and hydrate the corneal surface throughout the day. A notable example includes the PROSE Treatment developed by BostonSight, which utilizes customized scleral devices to support patients with severe ocular surface disease and complex corneal conditions.

North America Scleral Lens Market Trends

North America is anticipated to be the leading region, accounting for a 42% market share in 2026, driven by advanced ophthalmic infrastructure, broad access to specialty eye-care services, and strong practitioner awareness of scleral lens therapy. Art Optical Contact Lens, Inc., for instance, has expanded its specialty scleral lens portfolio and fitting technologies to support the management of keratoconus, irregular corneas, and complex ocular surface conditions.

U.S. Scleral Lens Market Trends

The U.S. is expected to dominate the regional market, accounting for approximately 87% of the North America market share in 2026. High awareness of specialty contact lenses among eye-care professionals supports strong adoption. Increasing diagnosis of keratoconus and ocular surface diseases continues to expand the patient pool. Advanced technologies such as corneal topography and scleral mapping are widely available. Specialty contact lens clinics are increasing across major metropolitan regions. Research institutions continue to generate clinical evidence supporting scleral lens use.

Canada Scleral Lens Market Trends

Canada is likely to be a significant market for scleral lenses, holding approximately 13% of the market share in 2026, supported by expanding access to specialty eye-care services. Optometrists and ophthalmologists are increasingly recommending scleral lenses for irregular corneas and severe dry eye conditions. Academic eye-care centers are strengthening practitioner training programs. Greater awareness among patients is improving acceptance of specialty contact lenses. Advanced diagnostic technologies are becoming more accessible across eye-care facilities.

Europe Scleral Lens Market Trends

Europe is likely to be a significant market for scleral lenses in 2026, due to a strong healthcare infrastructure, growing awareness of specialty contact lenses, and increasing demand for advanced corneal disease management. The region benefits from well-established ophthalmology networks and the rising adoption of customized lens technologies. A notable example includes Menicon Co., Ltd., which continues to strengthen its specialty contact lens portfolio and support advanced scleral lens fitting solutions.

U.K. Scleral Lens Market Trends

The U.K. is likely to be a significant market for scleral lenses, accounting for 15% of the Europe market share in 2026. Hospital-based ophthalmology centers and private clinics are expanding access to advanced contact lens services. Keratoconus management remains a major application area. The adoption of customized lens fitting technologies is improving patient outcomes. Professional education programs are supporting practitioner expertise in specialty lenses. Increased focus on non-invasive vision correction approaches is encouraging adoption.

Germany Scleral Lens Market Trends

Germany is anticipated to dominate the regional market, accounting for around 38% of the Europe market share in 2026, due to its advanced ophthalmic care infrastructure. The country has a strong network of specialty eye clinics and contact lens practitioners. Increasing focus on managing keratoconus and complex corneal disorders is driving demand. The adoption of digital imaging and customized fitting technologies continues to rise. German practitioners are increasingly integrating specialty lenses into treatment plans.

Asia Pacific Scleral Lens Market Trends

The Asia Pacific region is likely to be the fastest-growing region, driven by the improving healthcare infrastructure, increasing awareness of specialty eye-care solutions, and a large population affected by vision disorders. Rising diagnosis rates of keratoconus, dry eye disease, and corneal abnormalities are creating new growth opportunities. For instance, SEED Co., Ltd. continues to expand specialty contact lens technologies and contribute to innovation.

China Scleral Lens Market Trends

China is projected to dominate the Asia Pacific market, accounting for around 35% of the regional market share in 2026, driven by rising healthcare expenditure, which is improving access to advanced ophthalmic care. Increasing awareness of keratoconus and ocular surface disorders, growing demand for specialized vision correction solutions among urban populations, expanding specialty contact lens services at advanced eye hospitals, wider adoption of digital fitting technologies, and strong local manufacturing capabilities are further supporting market growth and improving access to customized lenses.

India Scleral Lens Market Trends

India is expected to account for approximately 20% of the Asia Pacific market share in 2026, due to increasing awareness of corneal disorders and specialty eye-care treatments. Expansion of ophthalmology hospitals and specialty clinics is improving patient access. The growing diagnosis of keratoconus is creating significant demand for advanced vision correction options. Practitioner training programs are increasing expertise in scleral lens fitting. Adoption of corneal imaging technologies is improving clinical outcomes.

The global scleral lens market exhibits a moderately fragmented structure, driven by the presence of both multinational vision-care companies and specialized specialty-contact-lens manufacturers focused on advanced corneal and ocular surface management. Continuous advancements in high-oxygen-permeable materials, digital fitting technologies, corneal mapping systems, and precision manufacturing techniques are reshaping the competitive environment.

With key leaders, including Bausch + Lomb, CooperVision Specialty EyeCare, ABB Optical Group, Art Optical Contact Lens, Inc., Menicon Co., Ltd., AccuLens, BostonSight, and Visionary Optics, the market remains innovation-focused and clinically driven. These players compete through product customization capabilities, specialty lens portfolios, practitioner training initiatives, strategic partnerships with eye-care institutions, and investments in advanced fitting technologies.

Key Industry Developments:

• In April 2026, BostonSight expanded its BostonSight SCLERAL lens portfolio by introducing new smaller-diameter lens options, enhancing fitting flexibility for pediatric patients and individuals with smaller corneas while broadening access to customized scleral lens therapy for complex ocular conditions.
• In May 2025, Bausch + Lomb launched Zenlens® CHROMA HOA™ in the United States, a wavefront-guided scleral lens technology designed to correct higher-order aberrations and improve visual clarity for patients with complex corneal irregularities such as keratoconus.